Association study of Plasmodium falciparum Acetyl-CoA Synthetase Mutations S868G and V949I with antimalarial drugs
Zhao, W.; Xiang, Z.; Zeng, W.; Qin, Y.; Pan, M.; Wu, Y.; Duan, M.; Mou, Y.; Liang, T.; Zhang, Y.; Liu, C.; Tang, X.; Huang, Y.; Yang, G.; Cui, L.; Yang, Z.
Show abstract
Plasmodium falciparum acetyl-CoA synthetase (PfACAS) protein is an important source of acetyl-CoA. We detected the mutations S868G and V949I in PfACAS by whole-genome sequencing analysis in some recrudescent parasites after antimalarial treatment with artesunate and dihydroartemisinin-piperaquine, suggesting that they may confer drug resistance. Using CRISPR/Cas9 technology, we engineered parasite lines carrying the PfACAS S868G and V949I mutations in two genetic backgrounds and evaluated their susceptibility to antimalarial drugs in vitro. The results demonstrated that PfACAS S868G and V949I mutations alone or in combination were not enough to provide resistance to antimalarial drugs.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Sodium Diethyldithiocarbamate antiparasitic activity against different Trypanosoma cruzi strains: Insights of its biological activity 94%
- Identification of novel genetic variants in the malaria vaccine candidate PfRh5: structure-guided insights into potential function 93%
- Identification of key interactions of benzimidazole resistance-associated amino acid mutations in Ascaris β-tubulins by molecular docking simulations 93%
Similar papers in this journal
- Accelerating antimalarial drug discovery with a new high-throughput screen for fast-killing compounds 94%
- Plasmodium falciparum Acetyl-CoA Synthetase is essential for parasite intraerythrocytic development and chromatin modification 93%
- Identification of antifungal agents AR-12 and Fosmanogepix as anti-Trypanosoma cruzi drugs through an enhanced fluorogenic β-galactosidase phenotypic screening assay 93%
Similar papers in this journal
Similar papers in this journal
- Chromosome splitting of Plasmodium berghei using the CRISPR/Cas9 system. 95%
- High-throughput phenotypic screen identifies a new family of potent anti-amoebic compounds 93%
- Serological evidence and factors associated to liver damage in malaria-typhoid infected patients consulting in two health facilities, Yaoundé-Cameroon 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.